Optic nerve magnetization transfer imaging and measures of axonal loss and demyelination in optic neuritis

Multiple Sclerosis

Volumn 13, Issue 7, 2007, Pages 875-879

  Trip, S A ^a,b   Schlottmann, P G ^b   Jones, S J ^c   Li, W Y ^c   Garway Heath, D F ^b   Thompson, A J ^a   Plant, G T ^b   Miller, D H ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b MOORFIELDS EYE HOSPITAL   (United Kingdom)

^c NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

Magnetization transfer imaging; MRI; Optic neuritis; Optical coherence tomography; Visual evoked potentials

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMYELINATION; DISEASE MARKER; EVOKED VISUAL RESPONSE; FEMALE; HUMAN; MALE; NERVE FIBER DEGENERATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE; OPTIC NEURITIS; OPTICAL COHERENCE TOMOGRAPHY; QUANTITATIVE STUDY; VISION TEST; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DEMYELINATING DISEASE; METHODOLOGY; MIDDLE AGED; MULTIPLE SCLEROSIS; NERVE FIBER; PATHOLOGY; PATHOPHYSIOLOGY; RETINA MACULA LUTEA;

ADULT; AXONS; DEMYELINATING DISEASES; EVOKED POTENTIALS, VISUAL; FEMALE; HUMANS; MACULA LUTEA; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; OPTIC NERVE; OPTIC NEURITIS; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 35848965689     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458507076952     Document Type: Article

References (21)

1. Van Buchem MA, Tofts PS. Magnetization transfer imaging. Neuroimaging Clin N Am 2000; 10: 771-88.
2. Barkhof F, Bruck W, De Groot CJ, Bergers E, Hulshof S, Geurts J et al. Remyelinated lesions in multiple sclerosis: magnetic resonance image appearance. Arch Neurol 2003; 60: 1073-81.
3. Schmierer K, Scaravilli F, Altmann DR, Barker GJ, Miller DH. Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain. Ann Neurol 2004; 56: 407-15.
4. Van Waesberghe JH, Kamphorst W, De Groot CJ, van Walderveen MA, Castelijns JA, Ravid R et al. Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann Neurol 1999; 46: 747-54.
5. Gass A, Moseley IF, Barker GJ, Jones S, MacManus D, McDonald WI et al. Lesion discrimination in optic neuritis using high-resolution fat-suppressed fast spinecho MRI. Neuroradiology 1996; 38: 317-21.
6. Halliday AM, McDonald WI, Mushin J. Delayed visual evoked response in optic neuritis. Lancet 1972; 1: 982-85.
7. Jones SJ, Brusa A. Neurophysiological evidence for long-term repair of MS lesions: implications for axon protection. J Neurol Sci 2003; 206: 193-98.
8. Huang D, Swanson EA, Lin CP, Schuman JS, Stinson WG, Chang W et al. Optical coherence tomography. Science 1991; 254: 1178-81.
9. Parisi V, Manni G, Spadaro M, Colacino G, Restuccia R, Marchi S et al. Correlation between morphological and functional retinal impairment in multiple sclerosis patients. Invest Ophthalmol Vis Sci 1999; 40: 2520-27.
10. Trip SA, Schlottmann PG, Jones SJ, Altmann DR, Garway-Heath DF, Thompson AJ et al. Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis. Ann Neurol 2005; 58: 383-91.
11. Fisher JB, Jacobs DA, Markowitz CE, Galetta SL, Volpe NJ, Nano-Schiavi ML et al. Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis. Ophthalmology 2006; 113: 324-32.
12. Costello F, Coupland S, Hodge W, Lorello GR, Koroluk J, Pan YI et al. Quantifying axonal loss after optic neuritis with optical coherence tomography. Ann Neurol 2006; 59: 963-69.
13. Trip SA, Schlottmann PG, Jones SJ, Li WY, Garway-Heath DF, Thompson AJ et al. Optic nerve atrophy and retinal nerve fibre layer thinning following optic neuritis: evidence that axonal loss is a substrate of MRI-detected atrophy. NeuroImage 2006: 31: 286-93.
14. Hickman SJ, Toosy AT, Jones SJ, Altmann DR, Miszkiel KA, MacManus DG et al. Serial magnetization transfer imaging in acute optic neuritis. Brain 2004; 127: 692-700.
15. Brusa A, Jones SJ, Plant GT. Long-term remyelination after optic neuritis: A 2-year visual evoked potential and psychophysical serial study. Brain 2001; 124: 468-79.
16. Ferris FL III, Kassoff A, Bresnick GH, Bailey I. New visual acuity charts for clinical research. Am J Ophthalmol 1982; 94: 91-96.
17. Farnsworth D. The Farnsworth-Munsell 100-hue and dichotomous tests for color vision. J Opt Soc Am 1943; 33: 568-78.
18. Thorpe JW, Barker GJ, Jones SJ, Moseley I, Losseff N, MacManus DG et al. Magnetisation transfer ratios and transverse magnetisation decay curves in optic neuritis: correlation with clinical findings and electrophysiology. J Neurol Neurosurg Psychiatry 1995; 59: 487-92.
19. Inglese M, Ghezzi A, Bianchi S, Gerevini S, Sormani MP, Martinelli V et al. Irreversible disability and tissue loss in multiple sclerosis: a conventional and magnetization transfer magnetic resonance imaging study of the optic nerves. Arch Neurol 2002; 59: 250-55.
20. Brusa A, Jones SJ, Kapoor R, Miller DH, Plant GT. Long-term recovery and fellow eye deterioration after optic neuritis, determined by serial visual evoked potentials. J Neurol 1999; 246: 776-82.
21. Arezzo JC, Brosnan CF, Schroeder CE, Litwak MS, Bornstein MB. Electrophysiological analysis of factors involved in the primary demyelinating diseases: the rabbit eye model system. Brain Res 1988; 462: 286-300.